Management for Pathologic N1-N2 Disease after Definitive Surgery for Clinical T1-2 N0 Rectal Cancer

被引：0
|
作者：
Polamraju, P. V. [1 ]
Haque, W. [2 ]
Verma, V. [3 ]
Wiederhold, L. R. [1 ]
Hatch, S. S. [4 ]
Butler, E. B. [2 ]
Teh, B. S. [2 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX 77555 USA
[2] Houston Methodist Hosp, Dept Radiat Oncol, Houston, TX USA
[3] Allegheny Gen Hosp, Dept Radiat Oncol, Pittsburgh, PA 15212 USA
[4] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SU_4_2036
引用
收藏
页码：E16 / E16
页数：1
相关论文
共 50 条
  • [21] Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2− Breast Cancer
    Maire J. Amlicke
    Jihye Park
    Chris B. Agala
    Dana L. Casey
    Emily M. Ray
    Stephanie M. Downs-Canner
    Philip M. Spanheimer
    [J]. Annals of Surgical Oncology, 2022, 29 : 7662 - 7669
  • [22] Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer
    Georges Vlastos
    Isabel T. Rubio
    Nadeem Q. Mirza
    Lisa A. Newman
    Ravi Aurora
    Julie Alderfer
    Aman U. Buzdar
    S. Eva Singletary
    [J]. Annals of Surgical Oncology, 2000, 7 : 581 - 587
  • [23] Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer
    Vlastos, G
    Rubio, IT
    Mirza, NQ
    Newman, LA
    Aurora, R
    Alderfer, J
    Buzdar, AU
    Singletary, SE
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (08) : 581 - 587
  • [24] Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer
    Andreis, D.
    Bonardi, S.
    Allevi, G.
    Aguggini, S.
    Gussago, F.
    Milani, M.
    Strina, C.
    Spada, D.
    Ferrero, G.
    Ungari, M.
    Rocca, A.
    Nanni, O.
    Roviello, G.
    Berruti, A.
    Harris, A. L.
    Fox, S. B.
    Roviello, F.
    Polom, K.
    Bottini, A.
    Generali, D.
    [J]. BREAST, 2016, 29 : 55 - 61
  • [25] Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer
    Selena J. An
    Emilie D. Duchesneau
    Paula D. Strassle
    Katherine Reeder-Hayes
    Kristalyn K. Gallagher
    David W. Ollila
    Stephanie M. Downs-Canner
    Philip M. Spanheimer
    [J]. npj Breast Cancer, 8
  • [26] Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer
    An, Selena J.
    Duchesneau, Emilie D.
    Strassle, Paula D.
    Reeder-Hayes, Katherine
    Gallagher, Kristalyn K.
    Ollila, David W.
    Downs-Canner, Stephanie M.
    Spanheimer, Philip M.
    [J]. NPJ BREAST CANCER, 2022, 8 (01)
  • [27] Prognostic value of histology grade and ki67 index in breast cancer (T1-2 N0 M0)
    Kudaybergenova, A.
    Rusaln, P.
    Komyahov, A.
    [J]. VIRCHOWS ARCHIV, 2015, 467 : S56 - S56
  • [28] Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer
    Oh, Seung Yeop
    Kim, Young Bae
    Suh, Kwang Wook
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 512 - 516
  • [29] Sentinel Node Navigation Surgery is Acceptable for Clinical T1 and N0 Esophageal Cancer
    Uenosono, Yoshikazu
    Arigami, Takaaki
    Yanagita, Shigehiro
    Kozono, Tsutomu
    Arima, Hideo
    Hirata, Munetsugu
    Kita, Yoshiaki
    Uchikado, Yasuto
    Okumura, Hiroshi
    Matsumoto, Masataka
    Natsugoe, Shoji
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (07) : 2003 - 2009
  • [30] Sentinel Node Navigation Surgery is Acceptable for Clinical T1 and N0 Esophageal Cancer
    Yoshikazu Uenosono
    Takaaki Arigami
    Shigehiro Yanagita
    Tsutomu Kozono
    Hideo Arima
    Munetsugu Hirata
    Yoshiaki Kita
    Yasuto Uchikado
    Hiroshi Okumura
    Masataka Matsumoto
    Shoji Natsugoe
    [J]. Annals of Surgical Oncology, 2011, 18 : 2003 - 2009
12345